ConductScience.org, home

Paper9687989

Mutational analysis of the TrkA gene in prostate cancer.

George DJ and 3 others. Prostate, 1998. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Mutational analysis of the TrkA gene in prostate cancer. Papers, record 9687989. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9687989

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mutational analysis of the TrkA gene in prostate cancer.
PubMed
Journal
Prostate
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
0.69
iCite
Revised in PubMed
2019-09-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1George DJD J
2Suzuki HH
3Bova GSG S
4Isaacs JTJ T

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MutationMajor topic
Nerve Growth FactorsMajor topic
Polymorphism, Single-Stranded ConformationalMajor topic
Prostatic NeoplasmsMajor topic
Proto-Oncogene ProteinsMajor topic
Receptor Protein-Tyrosine KinasesMajor topic
Receptors, Nerve Growth FactorMajor topic
Amino Acid Sequence
DNA Mutational Analysis
DNA Primers
Humans
Male
Molecular Sequence Data
Receptor, trkA

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
41742295NGF-mediated tumor-stroma crosstalk promotes prostate cancer aggressiveness.J Transl Med2026https://conductscience.org/library/papers/41742295PubMed
34268306Targeting the Nerve Growth Factor Signaling Impairs the Proliferative and Migratory Phenotype of Triple-Negative Breast Cancer Cells.Front Cell Dev Biol2021https://conductscience.org/library/papers/34268306PubMed
31937919Tumour innervation and neurosignalling in prostate cancer.Nat Rev Urol2020https://conductscience.org/library/papers/31937919PubMed
31527385Mouse Nerve Growth Factor Facilitates the Growth of Interspinal Schwannoma Cells by Activating NGF Receptors.J Korean Neurosurg Soc2019https://conductscience.org/library/papers/31527385PubMed
31174415Nerve Growth Factor Induces Proliferation and Aggressiveness In Prostate Cancer Cells.Cancers (Basel)2019https://conductscience.org/library/papers/31174415PubMed
30533196Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors.Oncotarget2018https://conductscience.org/library/papers/30533196PubMed
29914559The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII.J Exp Clin Cancer Res2018https://conductscience.org/library/papers/29914559PubMed
29715200TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis.J Clin Invest2018https://conductscience.org/library/papers/29715200PubMed
29666826Dr. Coffey's visionary contributions to urological research in China and Japan.Am J Clin Exp Urol2018https://conductscience.org/library/papers/29666826PubMed
25394774TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.Cancer Chemother Pharmacol2015https://conductscience.org/library/papers/25394774PubMed
22623209AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts.Cancer Chemother Pharmacol2012https://conductscience.org/library/papers/22623209PubMed
20003389c.1810C>T polymorphism of NTRK1 gene is associated with reduced survival in neuroblastoma patients.BMC Cancer2009https://conductscience.org/library/papers/20003389PubMed
19417027Trk receptor expression and inhibition in neuroblastomas.Clin Cancer Res2009https://conductscience.org/library/papers/19417027PubMed
18795122TRK-A, HER-2/neu, and KIT Expression/Activation Profiles in Salivary Gland Carcinoma.Transl Oncol2008https://conductscience.org/library/papers/18795122PubMed
15870692Methylation adjacent to negatively regulating AP-1 site reactivates TrkA gene expression during cancer progression.Oncogene2005https://conductscience.org/library/papers/15870692PubMed
15528978Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor.Invest New Drugs2005https://conductscience.org/library/papers/15528978PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
NGF4803PubTator's text mininghttps://conductscience.org/library/genes/4803NCBI Gene
NTRK14914PubTator's text mininghttps://conductscience.org/library/genes/4914NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9687989

GET https://conductscience.org/api/papers/v1/9687989/authors